Immunocytochemistry was used to determine SETD6 protein levels and it confirmed low basal level of SETD6 in the transformed cell line, SVHUC1, compared to bladder cancer cell lines (Figure 1D). The gene discussed is SETD6; the disease is urinary bladder carcinoma.